Mounjaro subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
So, yeah, thats been great
The largest national players combine insurance, PBM, and pharmacy services under one corporate roof
Related Reading Standard vs Microdose GLP-1: Semaglutide & Tirzepatide Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You
Your healthcare team can adjust your treatment plan, provide supportive management for side effects, or consider alternative therapies if GLP-1 receptor agonists are not suitable for you
It has been a total game-changer for my overall confidence and performance